Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

2007 guideline for the management of ureteral calculi.

BIBLIOGRAPHIC SOURCE(S)

  • EAU/AUA Nephrolithiasis Guideline Panel. Guideline for the management of ureteral calculi. Baltimore (MD): American Urological Association Education and Research, Inc., European Association of Urology; 2007. 61 p. [92 references]

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: American Urological Association (AUA), Ureteral Stones Guidelines Panel. Report on the management of ureteral calculi. Baltimore (MD): American Urological Association, Inc; 1997 Sep. 72 p. (Clinical practice guidelines; no. 9/97)

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Levels of evidence (Ia-IV), grades of the guideline statements (Standard, Recommendation, Option), and the index patient are defined at the end of the "Major Recommendations" field.

Treatment Guidelines for the Index Patient

For All Index Patients

Standard: Patients with bacteriuria should be treated with appropriate antibiotics. [Based on Panel consensus/Level IV]

Standard: Stone extraction with a basket without endoscopic visualization of the stone (blind basketing) should not be performed. [Based on Panel consensus/Level IV]

For Ureteral Stones <10 mm

Option: In a patient who has a newly diagnosed ureteral stone <10 mm and whose symptoms are controlled, observation with periodic evaluation is an option for initial treatment. Such patients may be offered an appropriate medical therapy to facilitate stone passage during the observation period. [Based on review of the data and panel opinion/Level IA]

Standard: Patients should be counseled on the attendant risks of medical expulsive therapy (MET) including associated drug side effects and should be informed that it is administered for an "off label" use. [Based on Panel consensus/Level IV]

Standard: Patients who elect for an attempt at spontaneous passage or MET should have well-controlled pain, no clinical evidence of sepsis, and adequate renal functional reserve. [Based on Panel consensus/Level IV]

Standard: Patients should be followed with periodic imaging studies to monitor stone position and to assess for hydronephrosis. [Based on Panel consensus/Level IV]

Standard: Stone removal is indicated in the presence of persistent obstruction, failure of stone progression, or in the presence of increasing or unremitting colic. [Based on Panel consensus/Level IV]

For Ureteral Stones >10 mm

For Patients Requiring Stone Removal

Standard: A patient must be informed about the existing active treatment modalities, including the relative benefits and risks associated with each modality. [Based on Panel consensus/Level IV]

Recommendation: For patients requiring stone removal, both shock-wave lithotripsy (SWL) and ureteroscopy (URS) are acceptable first-line treatments. [Based on review of the data and Panel consensus/Level IA-IV]

Recommendation: Routine stenting is not recommended as part of SWL. [Based on Panel consensus/Level III]

Option: Stenting following uncomplicated URS is optional. [Based on Panel consensus/Level IA]

Option: Percutaneous antegrade ureteroscopy is an acceptable first-line treatment in select cases. [Based on Panel consensus/Level III]

Option: Laparoscopic or open surgical stone removal may be considered in rare cases where SWL, URS, and percutaneous URS fail or are unlikely to be successful. [Based on Panel consensus/Level III]

Recommendations for the Pediatric Patient

Option: Both SWL and URS are effective in this population. Treatment choices should be based on the child's size and urinary tract anatomy. The small size of the pediatric ureter and urethra favors the less invasive approach of SWL. [Based on review of data and Panel consensus/Level III]

Recommendations for the Nonindex Patient

Standard: For septic patients with obstructing stones, urgent decompression of the collecting system with either percutaneous drainage or ureteral stenting is indicated. Definitive treatment of the stone should be delayed until sepsis is resolved. [Based on Panel consensus/Level III]

Definitions:

Levels of Evidence

Ia Evidence obtained from meta-analysis of randomized trials

Ib Evidence obtained from at least one randomized trial

IIa Evidence obtained from at least one well-designed controlled study without randomization

IIb Evidence obtained from at least one other type of well-designed quasi-experimental study

III Evidence obtained from well-designed nonexperimental studies, such as comparative studies, correlation studies, and case reports

IV Evidence obtained from expert committee reports, or opinions, or clinical experience of respected authorities

Grades of Guideline Statements

Standard: A guideline statement is a standard if: (1) the health outcomes of the alternative interventions are sufficiently well known to permit meaningful decisions, and (2) there is virtual unanimity about which intervention is preferred.

Recommendation: A guideline statement is a recommendation if: (1) the health outcomes of the alternative interventions are sufficiently well known to permit meaningful decisions, and (2) an appreciable but not unanimous majority agrees on which intervention is preferred.

Option: A guideline statement is an option if: (1) the health outcomes of the interventions are not sufficiently well known to permit meaningful decisions, or (2) preferences are unknown or equivocal.

Index Patient

In constructing these guidelines, an "index patient" was defined to reflect the typical individual with a ureteral stone whom a urologist treats. The following definition was created.

The index patient is a nonpregnant adult with a unilateral noncystine/nonuric acid radiopaque ureteral stone without renal calculi requiring therapy whose contralateral kidney functions normally and whose medical condition, body habitus, and anatomy allow any one of the treatment options to be undertaken.

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is identified and graded for each recommendation (see "Major Recommendations" field).

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • EAU/AUA Nephrolithiasis Guideline Panel. Guideline for the management of ureteral calculi. Baltimore (MD): American Urological Association Education and Research, Inc., European Association of Urology; 2007. 61 p. [92 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1997 Sep (revised 2007 Dec)

GUIDELINE DEVELOPER(S)

American Urological Association Education and Research, Inc. - Medical Specialty Society
European Association of Urology - Medical Specialty Society

SOURCE(S) OF FUNDING

The American Urological Association (AUA) and the European Association of Urology provided the funding.

GUIDELINE COMMITTEE

EAU/AUA Nephrolithiasis Guideline Panel and Consultants

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Names of Panel Members: Glenn M. Preminger, MD, (Chair); Hans-Göran Tiselius, MD, PhD, (Co-Chair); Dean G. Assimos, MD, (Vice Chair); Peter Alken, MD, PhD; Colin Buck, MD, PhD; Michele Gallucci, MD, PhD; Thomas Knoll, MD, PhD; James E. Lingeman, MD; Stephen Y. Nakada, MD; Margaret Sue Pearle, MD, PhD; Kemal Sarica, MD, PhD; Christian Türk, MD, PhD; J. Stuart Wolf, Jr., MD

Consultants: Hanan S. Bell, PhD; Patrick M. Florer

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Panel members received no remuneration for their work. Each member of the Practice Guidelines Committee and of the Panel furnished a current conflict of interest disclosure to the American Urological Association (AUA).

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: American Urological Association (AUA), Ureteral Stones Guidelines Panel. Report on the management of ureteral calculi. Baltimore (MD): American Urological Association, Inc; 1997 Sep. 72 p. (Clinical practice guidelines; no. 9/97)

GUIDELINE AVAILABILITY

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on September 1, 1998. It was verified by the guideline developer on December 1, 1998. This summary was updated by ECRI Institute on March 21, 2008. The updated information was verified by the guideline developer on April 1, 2008.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is copyrighted by the American Urological Association Education and Research, Inc. (AUA).

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo